FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2895983080> ?p ?o ?g. }

• W2895983080 abstract "Background Cluster of differentiation 40 ligand (CD40L) and rosuvastatin (RSV) affect atherosclerotic plaque stability, but little is known about their roles in extracellular matrix (ECM) production. We investigated the effects of CD40L and RSV on pre-existing advanced plaques. Methods and results Pre-existing advanced plaques were induced in apolipoprotein E-knockout (ApoE-/-) mice by the surgical placement of carotid constrictive silastic collars. Two weeks after surgery, mice were divided into the following treatment groups: control, empty adenovirus, CD40L adenovirus, CD40L adenovirus + RSV, and RSV. Mice received adenovirus via two tail-vein injections (2 × 109 pfu each) and/or RSV via intragastric administration (5 mg/kg; daily for 4 weeks). Mice in the CD40L adenovirus group exhibited increased plaque disruption rates, increased relative plaque macrophage and lipid content, reduced plaque collagen content, and increased local inflammation compared to the other treatment groups, but no significant differences in plaque area were observed among the groups. Notably, in the atherosclerotic plaques of the CD40L adenovirus group, both the mRNA and protein expression of prolyl-4-hydroxylase alpha 1 (P4Hα1) was significantly decreased, leading to a consequent decrease in the protein expression of collagen types I and III. Treatment with RSV decreased the serum levels of CD40L in a lipid-independent fashion and attenuated the effects of CD40L overexpression, particularly with respect to P4Hα1 downregulation. Conclusions CD40L destabilized advanced plaques in the carotid arteries of ApoE-/- mice, in part by decreasing P4Hα1 expression, and consequently collagen expression. These destabilizing effects were attenuated by RSV." @default.
• W2895983080 created "2018-10-26" @default.
• W2895983080 creator A5020987589 @default.
• W2895983080 creator A5027475930 @default.
• W2895983080 creator A5065599307 @default.
• W2895983080 creator A5082157709 @default.
• W2895983080 date "2018-12-01" @default.
• W2895983080 modified "2023-09-27" @default.
• W2895983080 title "Rosuvastatin stabilizes atherosclerotic plaques by reducing CD40L overexpression-induced downregulation of P4Hα1 in ApoE−/− mice" @default.
• W2895983080 cites W1966000886 @default.
• W2895983080 cites W1973321256 @default.
• W2895983080 cites W1982623307 @default.
• W2895983080 cites W1986238394 @default.
• W2895983080 cites W1990752520 @default.
• W2895983080 cites W1994629334 @default.
• W2895983080 cites W1997777898 @default.
• W2895983080 cites W2004777649 @default.
• W2895983080 cites W2005200459 @default.
• W2895983080 cites W2006225546 @default.
• W2895983080 cites W2010400642 @default.
• W2895983080 cites W2010412464 @default.
• W2895983080 cites W2011874786 @default.
• W2895983080 cites W2012152876 @default.
• W2895983080 cites W2016453184 @default.
• W2895983080 cites W2020940277 @default.
• W2895983080 cites W2030029123 @default.
• W2895983080 cites W2030564973 @default.
• W2895983080 cites W2040034904 @default.
• W2895983080 cites W2078027003 @default.
• W2895983080 cites W2079278713 @default.
• W2895983080 cites W2084072841 @default.
• W2895983080 cites W2091050865 @default.
• W2895983080 cites W2091401363 @default.
• W2895983080 cites W2093304844 @default.
• W2895983080 cites W2094629035 @default.
• W2895983080 cites W2099990733 @default.
• W2895983080 cites W2106410529 @default.
• W2895983080 cites W2109044040 @default.
• W2895983080 cites W2120221873 @default.
• W2895983080 cites W2125422089 @default.
• W2895983080 cites W2128605673 @default.
• W2895983080 cites W2143563923 @default.
• W2895983080 cites W2153575245 @default.
• W2895983080 cites W2154952909 @default.
• W2895983080 cites W2167327887 @default.
• W2895983080 cites W2344899129 @default.
• W2895983080 cites W2591905108 @default.
• W2895983080 cites W2592199962 @default.
• W2895983080 doi "https://doi.org/10.1016/j.biocel.2018.10.002" @default.
• W2895983080 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30336263" @default.
• W2895983080 hasPublicationYear "2018" @default.
• W2895983080 type Work @default.
• W2895983080 sameAs 2895983080 @default.
• W2895983080 citedByCount "3" @default.
• W2895983080 countsByYear W28959830802020 @default.
• W2895983080 countsByYear W28959830802022 @default.
• W2895983080 countsByYear W28959830802023 @default.
• W2895983080 crossrefType "journal-article" @default.
• W2895983080 hasAuthorship W2895983080A5020987589 @default.
• W2895983080 hasAuthorship W2895983080A5027475930 @default.
• W2895983080 hasAuthorship W2895983080A5065599307 @default.
• W2895983080 hasAuthorship W2895983080A5082157709 @default.
• W2895983080 hasConcept C104317684 @default.
• W2895983080 hasConcept C126322002 @default.
• W2895983080 hasConcept C127561419 @default.
• W2895983080 hasConcept C134018914 @default.
• W2895983080 hasConcept C154317977 @default.
• W2895983080 hasConcept C185592680 @default.
• W2895983080 hasConcept C202751555 @default.
• W2895983080 hasConcept C2776914184 @default.
• W2895983080 hasConcept C2778163477 @default.
• W2895983080 hasConcept C2779134260 @default.
• W2895983080 hasConcept C2780499067 @default.
• W2895983080 hasConcept C39347974 @default.
• W2895983080 hasConcept C55493867 @default.
• W2895983080 hasConcept C57089818 @default.
• W2895983080 hasConcept C62746215 @default.
• W2895983080 hasConcept C71924100 @default.
• W2895983080 hasConceptScore W2895983080C104317684 @default.
• W2895983080 hasConceptScore W2895983080C126322002 @default.
• W2895983080 hasConceptScore W2895983080C127561419 @default.
• W2895983080 hasConceptScore W2895983080C134018914 @default.
• W2895983080 hasConceptScore W2895983080C154317977 @default.
• W2895983080 hasConceptScore W2895983080C185592680 @default.
• W2895983080 hasConceptScore W2895983080C202751555 @default.
• W2895983080 hasConceptScore W2895983080C2776914184 @default.
• W2895983080 hasConceptScore W2895983080C2778163477 @default.
• W2895983080 hasConceptScore W2895983080C2779134260 @default.
• W2895983080 hasConceptScore W2895983080C2780499067 @default.
• W2895983080 hasConceptScore W2895983080C39347974 @default.
• W2895983080 hasConceptScore W2895983080C55493867 @default.
• W2895983080 hasConceptScore W2895983080C57089818 @default.
• W2895983080 hasConceptScore W2895983080C62746215 @default.
• W2895983080 hasConceptScore W2895983080C71924100 @default.
• W2895983080 hasLocation W28959830801 @default.
• W2895983080 hasLocation W28959830802 @default.
• W2895983080 hasOpenAccess W2895983080 @default.
• W2895983080 hasPrimaryLocation W28959830801 @default.
• W2895983080 hasRelatedWork W1960389768 @default.
• W2895983080 hasRelatedWork W1990495554 @default.

• next